We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Novel Bioluminescent Cell Metabolism Assays Integration with HP D300 Digital Dispenser...

Novel Bioluminescent Cell Metabolism Assays Integration with HP D300 Digital Dispenser and Tecan Gas Controlled Module Equipped Infinite M200 Pro Reader Poster

SEARCH POSTERS

Abstract

Gediminas Vidugiris1, Donna Leippe1, Mary Sobol1, Sarah Duellman1, Wenhui Zhou2, Jolanta Vidugiriene1, Jessica Merlino3, Michael Reitman4, Thomas Hengstl5, Poncho Meisenheimer2, Cristopher Cowan1, James Cali1
1Promega Corporation, Madison, WI; 2Promega Biosciences, LLC, San Luis Obispo, CA; 3Tecan Schweiz, Männedorf, Switzerland; 4Tecan US, Morrisville, NC; 5Tecan Austria GmbH, Groedig, Austria.

Robustness of bioluminescence assays makes them attractive and easily adoptable for automation and HTS applications. We describe the integration of Tecan, Hewlett Packard instrumentation capabilities with two of Promega's recently developed assays targeting cell metabolism applications:
1) Bioluminescence Live Cell Viability Assay and; 2) NAD(P)/NAD(P)H Detection Assays.

Document Icon Download the poster PDF (1051kb)

  • Part# PS173
  • Printed in USA.
Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom